Experienced international leadership team

Wei Chen, Ph.D., CEO

  • Ph.D. in Microbiology and Bioreaction Engineering from Nagoya University, Japan
  • Postdoctoral fellow at Yale University and the University of British Columbia
  • Faculty member at the School of Engineering and the School of Microbiology, UCLA
  • 30 years of biopharmaceutical industry experience managing biologics development and cGMP manufacturing
  • Oversaw hundreds of successful regulatory submissions and USFDA/EMA site inspections
  • Held key product development roles at BMS, J&J, Immunomedics, SAFC, and Phage Biotechnology
  • Lead the fast track commissioning of several cGMP facilities/operations in the United States, Europe and Asia from clinical- to commercial manufacturing

Jianmin Fang, Ph.D., Chairman

  • Ph.D. in Microbiology and Bioreaction Engineering from Nagoya University, Japan
  • Postdoctoral fellow at Yale University and the University of British Columbia
  • Faculty member at the School of Engineering and the School of Microbiology, UCLA
  • 30 years of biopharmaceutical industry experience managing biologics development and cGMP manufacturing
  • Oversaw hundreds of successful regulatory submissions and USFDA/EMA site inspections
  • Held key product development roles at BMS, J&J, Immunomedics, SAFC, and Phage Biotechnology
  • Lead the fast track commissioning of several cGMP facilities/operations in the United States, Europe and Asia from clinical- to commercial manufacturing

Marie Zhu, Ph.D., CEO of MabPlex USA

  • Ph.D. in Biochemical Engineering from the University of Wisconsin, Madison
  • Over 22 years of biotherapeutic development and manufacturing experience
  • Contributor to numerous successful IND and BLA filings for Biologics
  • Extensive experience building and leading teams and multi-functional operations including Cell Line Development, Cell Culture Process Development, Purification Process Development, Conjugation Process Development, Process Scale-up, Technology Transfer, and cGMP Manufacturing Operations.

Andrew C. Huang, Ph.D., CSO

  • Ph.D. from the University of Iowa, Post-Doctorate from UCLA
  • Distinguished expert Shandong Province “Taishan Scholar Project”
  • Over 20 years research experience in Biopharmaceuticals in the United States
  • More than 25 years experience in molecular medicine

James Ruan, Ph.D., SVP, Quality

  • Ph.D. from the University of Iowa, Post-Doctorate from UCLA
  • Distinguished expert Shandong Province “Taishan Scholar Project”
  • Over 20 years research experience in Biopharmaceuticals in the United States
  • More than 25 years experience in molecular medicine

Xinfang Li, Ph.D., VP of Process Development

  • Ph.D. in Molecular Biology and Biochemistry from Peking University in Beijing China
  • Post-Doctorate at Harvard University
  • Her work has directly impacted more than 20 product approvals by the FDA
  • Holds multiple patents and publications in Antibody Drug Conjugate preparation and purification technologies
  • She is an expert in viral clearance

Yong Deng, VP, Admin & HR

  • BSc. from Shandong University of TCM, Senior Economist
  • Over 20 years management in pharmaceutical enterprise, keen insight in corporate development
  • Rich experience in marketing strategy, corporate operation, and capital management